The efficacy, main diseases and clinical application effects of Bikken Pronol Tablets (Bituowei)

Biktarvy is an oral compound antiviral drug, composed of**Bictegravi (Bictegravi r), emtricitabine (Emtricitabine) and tenofovir fumarate (Tenofovir Alafenamide, TAF)**Composed. As a first-line anti-HIV-1 drug, it inhibits viral replication through multiple targets, reduces plasma viral load, and thereby improves immune function. It is currently one of the commonly used options for treating HIV infection.

The three ingredients of Bicronol tablets work synergistically: Biclutamide is an integrase inhibitor that can block the integration of HIV DNA into the host cell genome; emtricitabine and tenofovir are nucleoside reverse transcriptase inhibitors that inhibit viral replication by terminating viral DNA chain elongation. This combination therapy has the characteristics of efficient and long-lasting virus suppression and low risk of drug resistance. It can quickly reduce viral load, increase the number of CD4+ lymphocytes, and improve the body's immune function.

Bikon Prenol Tablets are mainly used for initial treatment or dressing change treatment in adults and children 12 years old and aboveHIV-1 infection. Clinical studies have shown that plasma HIV-1 levels in patients treated with Biktarvy range from 24 weeks to 48 weeks. The proportion of RNAinhibited to unmeasurable levels exceeded 90%, and the CD4+ cell count increased significantly, and the immune function was significantly improved. At the same time, the drug is convenient to take orally and can be administered as a single tablet once a day, which improves patient compliance.

In real-world and clinical trials, Bikernprenamide tablets have shown high efficacy, good tolerability and low drug resistance. Common adverse reactions are mild to moderate headache, diarrhea, nausea or mild rash, and the incidence of serious adverse events is low. Patients need to regularly monitor liver function, kidney function and viral load during use to ensure sustained and stable efficacy, and at the same time adjust the treatment plan in a timely manner. Overall, Biktarvy provides an efficient, safe and convenient medication option in the long-term management of HIV.

Reference materials:https://www.drugs.com/